Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: Comparison with conventional comparative genomic hybridization analysis

Cancer Genetics and Cytogenetics

Volumn 146, Issue 1, 2003, Pages 16-21

  Arai, Hiroshi ^a   Ueno, Takashi ^a   Tangoku, Akira ^a   Yoshino, Shigefumi ^a   Abe, Toshihiro ^a   Kawauchi, Shigeto ^a   Oga, Atsunori ^a   Furuya, Tomoko ^a   Oka, Masaaki ^a   Sasaki, Kohsuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; ESOPHAGUS CARCINOMA; FEMALE; GENE AMPLIFICATION; GENETIC CODE; HUMAN; MALE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

EID: 0141788552     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00106-7     Document Type: Article

References (18)

1. Lee D.J., Koch W.M., Yoo G., Longo M., Reed A., Califano J., Brennan J.A., Westra W.H., Zahurak M., Sidransky D. Impact of chro mosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res. 3:1997;501-505.
2. Knuutila S., Autio K., Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol. 157:2000;689.
3. Revillion F., Bonneterre J., Peyrat J.P. ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer. 34:1998;791-808.
4. Mitchell M.S., Press M.F. The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer. Semin Oncol. 26:1999;108-116.
5. Kallioniemi O.P., Kallioniemi A., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol. 4:1993;41-46.
6. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., Dairkee S.H., Ljung B.M., Gray J.W., Albertson D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 20:1998;207-211.
7. Hashimoto Y., Oga A., Okami K., Imate Y., Yamashita Y., Sasaki K. Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry. 40:2000;161-166.
8. Okafuji M., Ita M., Oga A., Hayatsu Y., Matsuo A., Shinzato Y., Shinozaki F., Sasaki K. The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas. J Oral Pathol Med. 29:2000;226-231.
9. Ueno T., Tangoku A., Yoshino S., Abe T., Toshimitsu H., Furuya T., Kawauchi S., Oga A., Oka M., Sasaki K. Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 8:2002;526-533.
10. Hermsen M.A., Meijer G.A., Baak J.P., Joenje H., Walboomers J.J. Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol. 27:1996;342-349.
11. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
12. Bentz M., Plesch A., Stilgenbauer S., Dohner H., Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer. 21:1998;172-175.
13. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., Brown P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet. 23:1999;41-46.
14. Akervall J.A., Michalides R.J., Mineta H., Balm A., Borg A., Dictor M.R., Jin Y., Loftus B., Mertens F., Wennerberg J.P. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 79:1997;380-389.
15. Rodrigo J.P., Garcia L.A., Ramos S., Lazo P.S., Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 6:2000;3177-3182.
16. Jin C., Mertens F., Jin Y., Wennerberg J., Heim S., Mitelman F. Complex karyotype with an 11q13 homogeneously staining region in esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 82:1995;175-176.
17. Schuuring E., Verhoeven E., Litviov S., Michalides R.J. The product of the EMS1 gene, amplification and oeverexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol. 13:1993;2891-2898.
18. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene. 159:1995;83-96.